Last updated on January 2019

Randomized Embedded Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Community Acquired Pneumonia
  • Age: Between 18 - 100 Years
  • Gender: Male or Female


  1. Adult patients admitted to an ICU for severe CAP within 48 hours of hospital admission with: i. symptoms or signs or both that are consistent with lower respiratory tract infection AND ii. Radiological evidence of new onset consolidation (in patients with pre-existing radiological changes, evidence of new infiltrate) 2. Requiring organ support with one or more of: i. Non-invasive ii. Invasive ventilatory support; iii. Receiving infusion of vasopressor or inotropes


  1. Healthcare-associated pneumonia:

Prior to this illness, has been i. an inpatient in any healthcare facility within the last 30 days ii. Resident of a nursing home or long term care facility

2. Death is deemed to be imminent or inevitable during this hospital admission AND one or more of the patient, substitute decision maker or attending physician are not committed to full active treatment

3. Previous participation in this REMAP within the last 90 days


Each domain may have additional eligibility criteria. Refer to the study website for more information (

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.